<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.0.1" -->
<rss version="0.92">
<channel>
	<title>Fatty Acid Trip: Adventures in High-EPA Fish Oil</title>
	<link>http://www.fattyacidtrip.com</link>
	<description>The latest research, book reviews, news articles and opinions on the benefits of omega-3 fatty acids and high EPA fish oil for the treatment of depression, mood disorders, ADHD, ADD, autism, learning disabilities, dyslexia, dyspraxia, sensory integration and more.</description>
	<lastBuildDate>Wed, 07 Oct 2009 16:53:50 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Can Fish Oil Improve Psychological Distress In Middle-Aged Women? A Best Evidence Review</title>
		<description>Charles P. Vega, MD, FAAFP reports on best evidence approaches for depression, anxiety and related issues for women in middle age:

Summary

Depression affects women disproportionately compared with men, and symptoms of psychological distress may be particularly prevalent during the perimenopausal period. The current study of ethyl-eicosapentaenoic acid for the management of ...</description>
		<link>http://www.fattyacidtrip.com/can-fish-oil-improve-psychological-distress-in-middle-aged-women-a-best-evidence-review/</link>
			</item>
	<item>
		<title>Omega-3 science review supports DRI for heart benefits</title>
		<description>A comprehensive review of studies on the benefits of omega-3 consumption has led scientists to recommend the establishment of a Dietary Reference Intake (DRI) for EPA and DHA to reduce the risk of heart disease.

The strength of evidence linking eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to a reduced risk ...</description>
		<link>http://www.fattyacidtrip.com/omega-3-science-review-supports-dri-for-heart-benefits/</link>
			</item>
	<item>
		<title>Omega-3 alleviates menopausal symptoms</title>
		<description>Two Canadian reports suggest that highly purified ethyl-eicosapentaenoic acid (E-EPA) omega-3 fatty acid supplementation may alleviate hot flushes and psychological distress in middle-aged women. The daily dosage was 1,050 grams in both trials.

The departments of Psychiatry and Obstetrics and Gynecology gynecology at Saint-François d'Assise Hospital (Centre Hospitalier Universitaire de Québec) ...</description>
		<link>http://www.fattyacidtrip.com/omega-3-alleviates-menopausal-symptoms/</link>
			</item>
	<item>
		<title>Omega-3 Fatty Acids May Help Cancer Patients Undergoing Major Operations</title>
		<description>New research from Trinity College Dublin published in this month's Annals of Surgery points to a potentially significant advance in the treatment of patients undergoing major cancer surgery.

The study was carried out by the oesophageal research group at Trinity College Dublin and St James's Hospital. A randomised controlled trial showed ...</description>
		<link>http://www.fattyacidtrip.com/omega-3-fatty-acids-may-help-cancer-patients-undergoing-major-operations/</link>
			</item>
	<item>
		<title>Flatulent cows could be curtailed by fish oils</title>
		<description>OK... This one I simply could not resist, courtesy of CNN.com:
(CNN) -- The benefits to humans of omega 3 fatty acids in fish oils are well documented, but a new study has found that fish oils can have a wider benefit to the environment -- by reducing the amount of ...</description>
		<link>http://www.fattyacidtrip.com/flatulent-cows-could-be-curtailed-by-fish-oils/</link>
			</item>
	<item>
		<title>Marine Omega-3 PUFAs Improve Arterial Elasticity in 2 Months</title>
		<description>With aging and vascular disease, arterial elasticity diminishes, bringing with it increased risk of hypertension, stroke and cardiovascular mortality. The consumption of omega-3 polyunsaturated fatty acids (n-3 PUFAs), both long-chain docosahexaenoic acid (DHA) and medium-chain alpha-linolenic acid, has modest blood pressure-lowering effects, but there is limited information about their effects ...</description>
		<link>http://www.fattyacidtrip.com/marine-omega-3-pufas-improve-arterial-elasticity-in-2-months/</link>
			</item>
	<item>
		<title>EPA Eases Anxiety in Substance Abusers</title>
		<description>Various studies have implicated low fish consumption or reduced blood levels of long-chain omega-3 fatty acids (n-3 LC-PUFAS) in the occurrence of various psychiatric disorders, alcoholism and among substance abusers. It has been known since 1996 that n-3 PUFAs, especially eicosapentaenoic acid (EPA), are reduced in major depression. A recent ...</description>
		<link>http://www.fattyacidtrip.com/epa-eases-anxiety-in-substance-abusers-2/</link>
			</item>
	<item>
		<title>EPA Plus Prozac Better Than Either Treatment Alone for Major Depression</title>
		<description>Long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs) have been used as an adjunct therapy in treating patients with major depressive disorder with mixed, but often encouraging, results. A meta-analysis of placebo-controlled trials concluded that n-3 PUFAs have significant antidepressant effects, but there are insufficient data to distinguish whether combined treatment ...</description>
		<link>http://www.fattyacidtrip.com/epa-plus-prozac-better-than-either-treatment-alone-for-major-depression/</link>
			</item>
	<item>
		<title>Scientists propose new marker for blood omega-3 levels</title>
		<description>US scientists have reported that the stable nitrogen isotope 15N may be a suitable biomarker to analyse blood levels of EPA and DHA intake in clinical and epidemiologic studies.

Scientists from the University of Alaska Fairbanks and the Fred Hutchinson Cancer Research Center in Seattle report that the ratio between 15N ...</description>
		<link>http://www.fattyacidtrip.com/scientists-propose-new-marker-for-blood-omega-3-levels/</link>
			</item>
	<item>
		<title>EPA Plus Statin Treatment Reduces Risk of Recurrent Stroke</title>
		<description>Readers of the PUFA Newsletter may recall the JELIS trial conducted among hypercholesterolemic patients treated with statins to lower their low-density lipoprotein cholesterol. Half the participants received 1.8 g/day of eicosapentaenoic acid (EPA) with their statin medication. Five years later, patients taking both a statin and EPA incurred significantly fewer ...</description>
		<link>http://www.fattyacidtrip.com/epa-plus-statin-treatment-reduces-risk-of-recurrent-stroke/</link>
			</item>
</channel>
</rss>
